Sinus Tarsi Implant as an Adjuvant Procedure to Medial Displacement Calcaneal Osteotomy in the Treatment of Mobile Adult Acquired Flatfoot Deformity
1 other identifier
interventional
130
1 country
10
Brief Summary
Background: Adult acquired flatfoot deformity (AAFD) is a deformity of the foot which leads to pain and an altered gait pattern. There are several different surgical interventions available for treatment of AAFD. One of the most common treatments for mobile AAFD is medial displacement calcaneal osteotomy (MDCO) with or without adjuvant soft tissue procedures. However, the medial displacement of the calcaneus only aims to correct the deformity in one plane despite AAFD being a deformity of three planes with hypereversion of the calcaneus, anterior translation of the talus over the calcaneus and tilting/drop of the calcaneal head. Because of these multiple forces, the healing of MDCO in the intended position can sometimes be hard to achieve and medial soft tissue is still stressed leading to recurring deformity. The investigators believe that adjuvant insertion of a sinus tarsi implant (STI) could work as an internal splint, protecting soft tissue procedures on the medial side, reversing anterior translation of the talus, opposing calcaneus eversion, and lifting talar head. This additional procedure will create a better correction of the deformity with enhanced appearance of the foot and better long-term functional results. Methods: This is a multi-center randomized controlled trial designed to assess the efficacy of STI as an adjuvant procedure to MDCO in patients with mobile AAFD (Stage II). Patients aged 16 to 75 years, referred to one of the orthopedic centers involved in this study, will be invited to participate if they fulfil the trials eligibility criteria. In total, 130 patients who provide informed consent will be randomized to either MDCO with STI or MDCO without STI (65 patients in each group). The included patients will be clinically and radiographically examined. They will also fill out a form before surgery and 4-5 months, 1 year and 2 years postoperatively. The form will include Self-Reported Foot and Ankle Score (SEFAS) and Euro-QoL 5 Dimensions (EQ-5D). The trials primary outcome will be change in Meary's angle. Secondary outcomes include additional radiographic changes, change in SEFAS score, EQ-5D index, pain according to visual analog scale (VAS), satisfaction assessment, clinical outcome measures, the length of postoperative sick-leave and rate of complications. Discussion: This is the first randomized controlled trial assessing the efficacy of a sinus tarsi implant as an adjuvant procedure to MDCO.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jul 2024
Longer than P75 for phase_4
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2023
CompletedFirst Posted
Study publicly available on registry
January 18, 2024
CompletedStudy Start
First participant enrolled
July 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
December 2, 2025
November 1, 2025
3.4 years
November 13, 2023
November 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Meary's angle
Change in degrees of Meary's angle
From baseline/preoperatively (max 6 months preoperatively) to 12 months postoperatively
Secondary Outcomes (20)
Meary's angle
From baseline/preoperatively (max 6 months preoperatively) to 4-5 and 24 months postoperatively
Calcaneal inclination angle
From baseline/preoperatively (max 6 months preoperatively) to 4-5, 12, and 24 months postoperatively
Talar declination angle
From baseline/preoperatively (max 6 months preoperatively) to 4-5, 12, and 24 months postoperatively
Talar-2nd metatarsal angle
From baseline/preoperatively (max 6 months preoperatively) to 4-5, 12, and 24 months postoperatively
Talar coverage angle
From baseline/preoperatively (max 6 months preoperatively) to 4-5, 12, and 24 months postoperatively
- +15 more secondary outcomes
Study Arms (2)
MDCO without STI
ACTIVE COMPARATOR1. For patients with preoperative gastrocnemius-soleus complex tightness, defined as a preoperative dorsal extension of the ankle less than 5 degrees, with the knee completely extended, a Strayer´s procedure will be performed before the other procedures. 2. MDCO will be performed where the distal aspect of the calcaneus is separated from the proximal aspects, slided medially and fixed with two screws. 3. After the MDCO, FDL will be transferred to the navicular bone. 4. The spring ligament will be assessed. If ruptured, it will be reconstructed. If not ruptured, it will be tightened. 5. A plantarflexing open wedge osteotomy of the medial cuneiform (Cotton osteotomy) will be performed if pre-/perioperative findings indicate it.
MDCO with STI
EXPERIMENTAL1. In patients with preoperative gastrocnemius-soleus complex tightness, defined as a preoperative dorsal extension of the ankle less than 5 degrees, with the knee completely extended, a Strayer´s procedure will be performed before the other procedures. 2. Thereafter, an STI (ProStop® Arthroereisis Subtalar Implant, Arthrex GmbH, Munich, Germany) will be inserted into the sinus tarsi. 3. MDCO will be performed where the distal aspect of the calcaneus is separated from the proximal aspects, slided medially and fixed with two screws. 4. After the MDCO, FDL will be transferred to the navicular bone. 5. The spring ligament will be assessed. If ruptured, it will be reconstructed. If not ruptured, it will be tightened. 6. A plantarflexing open wedge osteotomy of the medial cuneiform (Cotton osteotomy) will be performed if pre-/perioperative findings indicate it.
Interventions
Insertion of a sinus tarsi implant (ProStop from Arthrex) in sinus tarsi
MDCO - medial displacement calcaneal osteotomy FDL transfer - flexor digitorum longus tendon transfer to the navicular bone Spring ligament repair - reconstruction of the spring ligament Strayer's procedure - gastrocnemius recession (if necessary) Cotton osteotomy - medial cuneiform opening wedge osteotomy (if necessary)
Eligibility Criteria
You may qualify if:
- Patients with AAFD stage II, in whom the talonavicular uncoverage is not considered by the treating surgeon to require an additional lateral column lengthening
- Age 16-75 years, either sex
- Failed non-surgical treatment including 3 months of physiotherapy
You may not qualify if:
- Previous ipsilateral surgery for AAFD
- General hypermobility (Beighton score \> 6)
- Osteoarthritis in the hindfoot joints, ankle joint or first tarsometatarsal joint
- Rheumatoid arthritis
- Inability to answer patient-reported outcome measures (PROMs) due to language difficulties or cognitive disorder
- Current smoker
- Current pregnancy
- Severe medical illness
- Known abuse of drugs and/or alcohol
- Previous ipsilateral hindfoot fracture including Lisfranc injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Sites (10)
Department of Orthopedics - Hässleholm Hospital
Hässleholm, Skåne County, 281 38, Sweden
Department of Orthopedics - Skåne University Hospital Malmö
Malmo, Skåne County, 214 28, Sweden
Capio Ortho Center
Malmo, Skåne County, 215 32, Sweden
Capio Ortho Center Göteborg
Gothenburg, Västra Götaland County, Sweden
Department of Orthopedics - Eksjö Hospital
Eksjö, 575 81, Sweden
Department of Orthopedics - Falun Hospital
Falun, 791 82, Sweden
Department of Orthopedics - Sahlgrenska University Hospital
Mölndal, 431 80, Sweden
Department of Orthopedics - Östersund Hospital
Östersund, 831 83, Sweden
Department of Orthopedics - Uppsala University Hospital
Uppsala, 751 85, Sweden
Department of Orthopedics - Växjö
Vaxjo, 352 34, Sweden
Related Publications (12)
Ellis SJ, Yu JC, Williams BR, Lee C, Chiu YL, Deland JT. New radiographic parameters assessing forefoot abduction in the adult acquired flatfoot deformity. Foot Ankle Int. 2009 Dec;30(12):1168-76. doi: 10.3113/FAI.2009.1168.
PMID: 20003875BACKGROUNDIossi M, Johnson JE, McCormick JJ, Klein SE. Short-term radiographic analysis of operative correction of adult acquired flatfoot deformity. Foot Ankle Int. 2013 Jun;34(6):781-91. doi: 10.1177/1071100713475432. Epub 2013 Feb 5.
PMID: 23386748BACKGROUNDJordan TH, Rush SM, Hamilton GA, Ford LA. Radiographic outcomes of adult acquired flatfoot corrected by medial column arthrodesis with or without a medializing calcaneal osteotomy. J Foot Ankle Surg. 2011 Mar-Apr;50(2):176-81. doi: 10.1053/j.jfas.2010.12.008.
PMID: 21354002BACKGROUNDMattesi L, Ancelin D, Severyns MP. Is subtalar arthroereisis a good procedure in adult-acquired flatfoot? A systematic review of the literature. Orthop Traumatol Surg Res. 2021 Oct;107(6):103002. doi: 10.1016/j.otsr.2021.103002. Epub 2021 Jun 30.
PMID: 34216843BACKGROUNDMercun A, Kovacic B, Suhodolcan L, Drobnic M. Patient Outcomes Following Extra-Osseous Talo-Tarsal Stabilization for Foot Hyperpronation. J Foot Ankle Surg. 2022 Mar-Apr;61(2):318-322. doi: 10.1053/j.jfas.2021.09.002. Epub 2021 Sep 9.
PMID: 34600818BACKGROUNDMyerson MS, Badekas A, Schon LC. Treatment of stage II posterior tibial tendon deficiency with flexor digitorum longus tendon transfer and calcaneal osteotomy. Foot Ankle Int. 2004 Jul;25(7):445-50. doi: 10.1177/107110070402500701.
PMID: 15319100BACKGROUNDOsbeck I, Coster M, Montgomery F, Atroshi I. Surgically treated adult acquired flatfoot deformity: Register-based study of patient characteristics, health-related quality of life and type of surgery according to severity. Foot Ankle Surg. 2023 Jun;29(4):367-372. doi: 10.1016/j.fas.2023.03.003. Epub 2023 Mar 15.
PMID: 36948921BACKGROUNDOzan F, Dogar F, Gencer K, Koyuncu S, Vatansever F, Duygulu F, Altay T. Symptomatic flexible flatfoot in adults: subtalar arthroereisis. Ther Clin Risk Manag. 2015 Oct 16;11:1597-602. doi: 10.2147/TCRM.S90649. eCollection 2015.
PMID: 26527876BACKGROUNDReilingh ML, Beimers L, Tuijthof GJ, Stufkens SA, Maas M, van Dijk CN. Measuring hindfoot alignment radiographically: the long axial view is more reliable than the hindfoot alignment view. Skeletal Radiol. 2010 Nov;39(11):1103-8. doi: 10.1007/s00256-009-0857-9. Epub 2010 Jan 9.
PMID: 20062985BACKGROUNDSaxena A, Via AG, Maffulli N, Chiu H. Subtalar Arthroereisis Implant Removal in Adults: A Prospective Study of 100 Patients. J Foot Ankle Surg. 2016 May-Jun;55(3):500-3. doi: 10.1053/j.jfas.2015.12.005. Epub 2016 Feb 11.
PMID: 26874830BACKGROUNDViladot Voegeli A, Fontecilla Cornejo N, Serra Sandoval JA, Alvarez Goenaga F, Viladot Perice R. Results of subtalar arthroereisis for posterior tibial tendon dysfunction stage IIA1. Based on 35 patients. Foot Ankle Surg. 2018 Feb;24(1):28-33. doi: 10.1016/j.fas.2016.10.006. Epub 2016 Nov 5.
PMID: 29413770BACKGROUNDWalley KC, Greene G, Hallam J, Juliano PJ, Aynardi MC. Short- to Mid-Term Outcomes Following the Use of an Arthroereisis Implant as an Adjunct for Correction of Flexible, Acquired Flatfoot Deformity in Adults. Foot Ankle Spec. 2019 Apr;12(2):122-130. doi: 10.1177/1938640018770242. Epub 2018 Apr 12.
PMID: 29644885BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ida Osbeck, MD
Region Skane
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2023
First Posted
January 18, 2024
Study Start
July 31, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2029
Last Updated
December 2, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
We plan to publish the results of our findings in a scientific journal. Data will be published on a population level and no IPD will be shared with other researchers.